Immunoglobulin replacement products in current clinical use in the United States have poor neutralizing activity against SARS-CoV-2 Omicron strains

por Doss, Alexa, Liang, Chieh-Yu, Monroy, Jennifer, Wedner, James, Rigell, Christopher, Davis-Adams, Hannah, Adams, Lucas, Kendall, Peggy, Diamond, Michael, Zimmerman, Ofer
Publicado 2023